title: [Possible malignant neuroleptic syndrome associated with aripiprazole and imipramine and treated with bromocriptine].
authors.affiliation: Servicio de Farmacia, Hospital Universitario Severo Ochoa, Madrid, España. Electronic address: elopezlunar@gmail.com.
authors.forename: Elena
authors.initials: E
authors.lastname: Lopez
authors.forename: Sonia
authors.initials: S
authors.lastname: Fraile
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Hidalgo
authors.forename: Benito
authors.initials: B
authors.lastname: García
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000068180:Aripiprazole; D001971:Bromocriptine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D004630:Emergencies; D057180:Frontotemporal Dementia / Q000188:drug therapy; D006801:Humans; D007099:Imipramine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008140:Lorazepam / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy; D010102:Oxygen Inhalation Therapy; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D015363:Quinolones / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000209:etiology / Q000628:therapy
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D001971:Bromocriptine; D000068180:Aripiprazole; C023842:lormetazepam; D008140:Lorazepam; D007099:Imipramine